Evidence mapPaperPMID 42465263Full record

ArticlebioRxiv : the preprint server for biology2026

IFN𝛾 and IFN𝛾 mimetics prevent IFN-I-mediated TB susceptibility by regulating iron metabolism and lipid peroxidation.

Prasanna Babu Araveti, Shivraj M Yabaji, Muhammad Zainul Arifin, Suruchi Lata, Yuriy O Alekseyev, Alexander A Gimelbrant, William R Bishai, Vadim Zhernovkov, Oleksii S Rukhlenko, Boris N Kholodenko and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Prasanna Babu AravetiThe National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.ORCID 0000-0002-5441-3826
Shivraj M YabajiThe National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.ORCID 0000-0002-5793-1661
Muhammad Zainul ArifinSystems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0003-3436-7380
Suruchi LataThe National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.ORCID 0000-0001-5548-9315
Yuriy O AlekseyevThe Department of Pathology and Laboratory Medicine, Boston University Chobanian Avedisian School of Medicine, Boston, United States.ORCID 0000-0001-6105-8861
Alexander A GimelbrantAltius Institute for Biomedical Sciences, Seattle, United States.ORCID 0000-0001-6986-0285
William R BishaiCenter for TB Research, Johns Hopkins School of Medicine, Baltimore, United States.ORCID 0000-0002-8734-4118
Vadim ZhernovkovSystems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0001-8903-1142
Oleksii S RukhlenkoSystems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0003-1863-4987
Boris N KholodenkoSystems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0002-9483-4975
Igor KramnikThe National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.ORCID 0000-0001-6511-9246

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I interferons (IFN-I) and IFNγ exert divergent effects during tuberculosis, but the mechanisms that determine whether macrophage activation promotes host defense or inflammatory pathology remain incompletely understood. Here, we dissect the interplay between IFN-I and IFNγ in macrophage activation using genetically susceptible B6.Sst1S macrophages. We show that, during tumor necrosis factor (TNF) stimulation, susceptible macrophages enter a persistent pathological activation state (pPAS) characterized by sustained lipid peroxidation and super-induction of IFN-I responses. This pathological state is maintained by autocrine IFN-I signaling. In contrast, IFNγ priming prevents pPAS development by enhancing macrophage resilience to oxidative stress, in part through regulation of iron metabolism and induction of ferritin expression. Computational

Identifiers

PMID42465263
PMCPMC13370422

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.